Evidence map›Paper›PMID 33510029›Full record

ArticleScience (New York, N.Y.)2021

MAIT cell activation augments adenovirus vector vaccine immunogenicity.

Nicholas M Provine, Ali Amini, Lucy C Garner, Alexandra J Spencer, Christina Dold, Claire Hutchings, Laura Silva Reyes, Michael E B FitzPatrick, Senthil Chinnakannan, Blanche Oguti and 13 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Targeting T follicular helper cells for lifelong health.Nature reviews. Drug discovery · 2026
    Review
  5. Gut archaea drive human MAIT cell responses.bioRxiv : the preprint server for biology · 2026
    Article
  6. Avoidance of MAIT cells is an essential determinant ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. BNT162b2 COVID-19 vaccination elicits the expansion of CD16The Journal of allergy and clinical immunology · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. MAIT cells modulating the oral lichen planus immune microenvironment: a cellular crosstalk perspective.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 2 countries.

Nicholas M ProvineTranslational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK. nicholas.provine@ndm.ox.ac.uk paul.klenerman@ndm.ox.ac.uk.ORCID https://orcid.org/0000-0002-9694-2216
Ali AminiTranslational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-6837-8881
Lucy C GarnerTranslational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-6461-252X
Alexandra J SpencerJenner Institute, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0001-7958-6961
Christina DoldOxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.
Claire HutchingsPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-7858-6924
Laura Silva ReyesOxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.ORCID https://orcid.org/0000-0002-3678-1836
Michael E B FitzPatrickTranslational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Senthil ChinnakannanPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Blanche OgutiOxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.ORCID https://orcid.org/0000-0001-9087-9992
Meriel RaymondOxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.ORCID https://orcid.org/0000-0002-0442-9280
Marta UlaszewskaJenner Institute, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0003-4288-2892
Fulvia TroiseNouscom, SRL, Rome, Italy.ORCID https://orcid.org/0000-0002-4815-1495
Hannah SharpeJenner Institute, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-1194-2429
Sophie B MorganRespiratory Medicine Unit, Nuffield Department of Medicine - Experimental Medicine, University of Oxford, Oxford, UK.
Timothy S C HinksRespiratory Medicine Unit, Nuffield Department of Medicine - Experimental Medicine, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0003-0699-2373
Teresa LambeJenner Institute, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0001-7711-897X
Stefania CaponeReiThera, SRL, Rome, Italy.ORCID https://orcid.org/0000-0002-2272-120X
Antonella FolgoriReiThera, SRL, Rome, Italy.ORCID https://orcid.org/0000-0001-8951-6633
Eleanor BarnesTranslational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-0860-0831
Christine S RollierOxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.ORCID https://orcid.org/0000-0002-9712-8080
Andrew J PollardOxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.ORCID https://orcid.org/0000-0001-7361-719X
Paul KlenermanTranslational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK. nicholas.provine@ndm.ox.ac.uk paul.klenerman@ndm.ox.ac.uk.ORCID https://orcid.org/0000-0003-4307-9161
University of Oxford · GBNational Institute for Health Research · GBNuffield Orthopaedic Centre · GBCeinge Biotecnologie Avanzate (Italy) · IT

Funding

Cancer Research UK 23521Cancer Research UK 29991Medical Research Council MC_PC_13073Medical Research Council MC_PC_20060Medical Research Council MR/M007693/1Medical Research Council MR/R014485/1Medical Research Council MR/V028448/1Wellcome Trust 109965Wellcome Trust 109965/Z/15/ZWellcome Trust 211050/Z/18/Z
6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells are innate sensors of viruses and can augment early immune responses and contribute to protection. We hypothesized that MAIT cells may have inherent adjuvant activity in vaccine platforms that use replication-incompetent adenovirus vectors. In mice and humans, ChAdOx1 (chimpanzee adenovirus Ox1) immunization robustly activated MAIT cells. Activation required plasmacytoid dendritic cell (pDC)-derived interferon (IFN)-α and monocyte-derived interleukin-18. IFN-α-induced, monocyte-derived tumor necrosis factor was also identified as a key secondary signal. All three cytokines were required in vitro and in vivo. Activation of MAIT cells positively correlated with vaccine-induced T cell responses in human volunteers and MAIT cell-deficient mice displayed impaired CD8

Indexed as

Immunogenicity, VaccineAdenoviridaeAnimalsCD8-Positive T-LymphocytesDendritic CellsGenetic VectorsHumansInterferon-alphaInterleukin-18Lymphocyte ActivationMiceMice, Inbred C57BLMucosal-Associated Invariant T CellsTumor Necrosis Factor-alphaViral VaccinesInterferon-alphaInterleukin-18Tumor Necrosis Factor-alphaViral Vaccines

Identifiers

PMID33510029
PMCPMC7610941
OpenAlexW3112115390

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.